Literature DB >> 10433510

Functional analysis of desensitization of the beta-adrenoceptor signalling pathway in rat cardiac tissues following chronic isoprenaline infusion.

L McMartin1, R J Summers.   

Abstract

1. This study examined beta-adrenoceptor signalling in cardiac tissues following infusion of isoprenaline (400 microg kg(-1) h(-1)) or vehicle to rats for 14 days. 2. Isoprenaline infusion caused marked hypertrophy of atria and ventricles and reduced the resting rate of spontaneously beating right atria and the basal force of left atrial contraction. 3. In spontaneously beating right atria, concentration-response curves to isoprenaline and forskolin were shifted 7.9 and 3.2 fold to the right following treatment whereas responses to the cyclic AMP analogue 5,6-dichloro-1-beta-D-ribofuranosylbenzimidazole-3', 5'-cyclic monophosphorothioate were unchanged. 4. In electrically driven left atria, concentration-response curves to isoprenaline and forskolin were shifted 4 fold to the right and maximum responses reduced. Responses to dibutyryl cyclic AMP were shifted 3.2 fold to the right but those to Ca2+ were unchanged. 5. Inotropic responses of left and right ventricular papillary muscles to isoprenaline were abolished and markedly reduced respectively by isoprenaline treatment. Responses to forskolin were shifted 5 fold to the right. Responses to dibutyryl cyclic AMP were shifted to the right 3.2 and 2 fold in left and right ventricular papillary muscles. Responses to isobutyl methyl xanthine were shifted to the right 15.8 and 6.3 fold in left and right papillary muscles whereas those to Ca2+ were not significantly altered. 6. This study indicates differences in beta-adrenoceptor desensitization in different regions of the heart following chronic infusion of isoprenaline. Chronotropic responses showed impaired signalling between the receptor and adenylate cyclase whereas inotropic responses exhibited additional desensitization at the level of cyclic AMP dependent protein kinase.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10433510      PMCID: PMC1566094          DOI: 10.1038/sj.bjp.0702618

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  38 in total

1.  Effects of prolonged isoproterenol infusion on cardiac and vascular responses to adrenoceptor agonists.

Authors:  J S Hayes; V L Wyss; K S Schenck; M L Cohen
Journal:  J Pharmacol Exp Ther       Date:  1986-06       Impact factor: 4.030

2.  Affinities of full agonists for cardiac beta-adrenoceptors calculated by use of in vitro desensitization.

Authors:  M L Herepath; K J Broadley
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1990-06       Impact factor: 3.000

3.  Differential rates of down regulation and recovery of rat myocardial beta-adrenoceptor subtypes in vivo.

Authors:  X Y Lu; D B Barnett
Journal:  Eur J Pharmacol       Date:  1990-07-17       Impact factor: 4.432

4.  A different desensitization pattern of cardiac beta-adrenoceptor subtypes by prolonged in vivo infusion of isoprenaline.

Authors:  C Nanoff; M Freissmuth; E Tuisl; W Schütz
Journal:  J Cardiovasc Pharmacol       Date:  1989-02       Impact factor: 3.105

5.  Mechanism of noradrenaline-induced heterologous desensitization of adenylate cyclase stimulation in rat heart muscle cells: increase in the level of inhibitory G-protein alpha-subunits.

Authors:  C Reithmann; P Gierschik; D Sidiropoulos; K Werdan; K H Jakobs
Journal:  Eur J Pharmacol       Date:  1989-08-15       Impact factor: 4.432

6.  Differential regulation of beta-1 and beta-2 adrenoceptors in guinea pig atrioventricular conducting system after chronic (-)-isoproterenol infusion.

Authors:  P Molenaar; J J Smolich; F D Russell; L R McMartin; R J Summers
Journal:  J Pharmacol Exp Ther       Date:  1990-10       Impact factor: 4.030

7.  Beta 1- and beta 2-adrenoceptor binding and functional response in right and left atria of rat heart.

Authors:  E N Juberg; K P Minneman; P W Abel
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1985-09       Impact factor: 3.000

8.  Cardiac alpha- and beta-adrenoceptor sensitivity and binding characteristics after chronic reserpine pretreatment.

Authors:  R G Chess-Williams; P F Grassby; K J Broadley; D J Sheridan
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-12       Impact factor: 3.000

9.  Contraction of cardiac myocytes from noradrenaline-treated rats in response to isoprenaline, forskolin and dibutyryl cAMP.

Authors:  S M Jones; N A Hunt; F Del Monte; S E Harding
Journal:  Eur J Pharmacol       Date:  1990-11-27       Impact factor: 4.432

10.  Pseudomonas exotoxin A prevents beta-adrenoceptor-induced upregulation of Gi protein alpha-subunits and adenylyl cyclase desensitization in rat heart muscle cells.

Authors:  C Reithmann; P Gierschik; U Müller; K Werdan; K H Jakobs
Journal:  Mol Pharmacol       Date:  1990-05       Impact factor: 4.054

View more
  3 in total

1.  Contractile responses to selective phosphodiesterase inhibitors following chronic beta-adrenoreceptor activation.

Authors:  Oleg E Osadchii; Angela J Woodiwiss; Gavin R Norton
Journal:  Pflugers Arch       Date:  2005-12-17       Impact factor: 3.657

Review 2.  Cardiac hypertrophy induced by sustained beta-adrenoreceptor activation: pathophysiological aspects.

Authors:  Oleg E Osadchii
Journal:  Heart Fail Rev       Date:  2007-03-27       Impact factor: 4.654

3.  Cardiac contractile reserve parameters are related to prognosis in septic shock.

Authors:  Antoine Kimmoun; Nicolas Ducrocq; Sébastien Mory; Remi Delfosse; Laura Muller; Pierre Perez; Renaud Fay; Bruno Levy
Journal:  Biomed Res Int       Date:  2013-07-17       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.